Pharmacotherapy of ovarian hyperstimulation syndrome

Author： Genazzani Andrea Riccardo   Monteleone Patrizia   Papini Francesca   Artini Paolo Giovanni  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.15, 2010-10, pp. : 2527-2534

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetics of ovarian hyperstimulation syndrome

By Rizk Botros  

Reproductive BioMedicine Online, Vol. 19, Iss. 1, 2009-07 ,pp. : 14-27

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Ovarian hyperstimulation syndrome: strategies for prevention

By Chen Dehan   Burmeister Lynn   Goldschlag Dan   Rosenwaks Zev  

Reproductive BioMedicine Online, Vol. 7, Iss. 1, 2003-07 ,pp. : 43-49

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Triptorelin: Ovarian hyperstimulation syndrome: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1241, 2009-01 ,pp. : 39-40

Adis International

Access to resources Recommend Favorite

Chorionic gonadotropin: Ovarian hyperstimulation syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1284, 2010-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Triptorelin: Ovarian hyperstimulation syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1318, 2010-01 ,pp. : 44-44

Adis International

Access to resources Recommend Favorite